Cantor Fitzgerald Downgrades ADMA Biologics to Neutral

Benzinga Newsdesk www.benzinga.com Negative 91.9%

Neg 91.9% Neu 0% Pos 0%

Cantor Fitzgerald analyst Kristen Kluska downgrades ADMA Biologics (NASDAQ:ADMA) from Overweight to Neutral.

Comments

No comments yet. Be the first!